مشارکت دولتی و خصوصی بیماری آلزایمر / Alzheimer’s disease public-private partnerships

مشارکت دولتی و خصوصی بیماری آلزایمر Alzheimer’s disease public-private partnerships

  • نوع فایل : کتاب
  • زبان : انگلیسی
  • ناشر : Elsevier
  • چاپ و سال / کشور: 2018

توضیحات

رشته های مرتبط پزشکی
گرایش های مرتبط روانپزشکی
مجله آلزایمر و ضعف – Alzheimer’s and Dementia
دانشگاه Medical & Scientific Relations Division – Alzheimer’s Association – USA
شناسه دیجیتال – doi https://doi.org/10.1016/j.jalz.2017.12.009
منتشر شده در نشریه الزویر
کلمات کلیدی انگلیسی Alzheimer’s disease; Collaborations; Private-public partnerships; Public policy; International efforts; Neuroscience

Description

1. Introduction There are greater than five million Americans living with Alzheimer’s dementia and more than 35 million people worldwide [1], and without a way to stop or slow the progression, there will be nearly a tripling of individuals affected by 2050 (13.8 million) [1]. The urgency to develop an intervention to stop or slow the progression of Alzheimer’s disease (AD) [2,3] is driving collaborations both within and between federal/governmental agencies, industrial/for-profit organizations, and nonprofit entities. Since 2013, the Alzheimer’s Association has taken the lead on working with the global nonprofit community to compile and publish compendium on the landscape of the changing landscape of private-public partnerships between these organizations and other stakeholders[4]. This compendium of global and regional private-public partnerships between governmental/federal entities, industrial/for-profit organizations, and nonprofit organizations invested in the AD research landscape was updated in 2014 [5]. Given the continuing growth of the landscape, the compendium requires update of the rapidly growing number of organizations involved, their varied goals, and their relationships with one another. The following sections include the mission statements of 25 nonprofit/charity organizations and their collaborative partnerships with governmental, global, and industrial entities, with an emphasis on the nature of collaborative efforts (i.e., improving clinical trials, obtaining and sharing data, supporting individuals with dementia and caregivers, and research funding).
اگر شما نسبت به این اثر یا عنوان محق هستید، لطفا از طریق "بخش تماس با ما" با ما تماس بگیرید و برای اطلاعات بیشتر، صفحه قوانین و مقررات را مطالعه نمایید.

دیدگاه کاربران


لطفا در این قسمت فقط نظر شخصی در مورد این عنوان را وارد نمایید و در صورتیکه مشکلی با دانلود یا استفاده از این فایل دارید در صفحه کاربری تیکت ثبت کنید.

بارگزاری